atai Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit
atai Life Sciences (NASDAQ: ATAI), a clinical-stage biopharmaceutical company focused on transforming mental health disorder treatments, has announced its participation in the 2024 Maxim Healthcare Virtual Summit. The event is scheduled from October 15 – 17, 2024.
Key details of atai's involvement include:
- Participant: Srinivas Rao, M.D., Ph.D., Co-founder and Co-CEO
- Format: Virtual fireside chat
- Date: Wednesday, October 16, 2024
- Presentation Time: 3:30 P.M. EDT
A webcast registration link is provided, and an archived replay will be available on the Investors section of atai's website under Events for up to 30 days after the presentation.
atai Life Sciences (NASDAQ: ATAI), un'azienda biofarmaceutica in fase clinica focalizzata sulla trasformazione dei trattamenti per i disturbi mentali, ha annunciato la sua partecipazione al Summit Virtuale Maxim Healthcare 2024. L'evento è programmato dal 15 al 17 ottobre 2024.
Dettagli chiave del coinvolgimento di atai includono:
- Partecipante: Srinivas Rao, M.D., Ph.D., Co-fondatore e Co-CEO
- Formato: Discussione virtuale informale
- Data: Mercoledì 16 ottobre 2024
- Orario della presentazione: 15:30 EDT
È fornito un link per la registrazione al webcast e sarà disponibile una registrazione archiviata nella sezione Investitori del sito web di atai sotto Eventi per un massimo di 30 giorni dopo la presentazione.
atai Life Sciences (NASDAQ: ATAI), una compañía biofarmacéutica en etapa clínica enfocada en transformar los tratamientos de los trastornos mentales, ha anunciado su participación en la Cumbre Virtual Maxim Healthcare 2024. El evento está programado para el 15 al 17 de octubre de 2024.
Los detalles clave sobre la participación de atai incluyen:
- Participante: Srinivas Rao, M.D., Ph.D., Co-fundador y Co-CEO
- Formato: Charla virtual informal
- Fecha: Miércoles, 16 de octubre de 2024
- Hora de presentación: 3:30 P.M. EDT
Se proporciona un enlace de registro para el webcast y habrá una repetición archivada disponible en la sección de Inversores del sitio web de atai bajo Eventos durante un máximo de 30 días después de la presentación.
atai Life Sciences (NASDAQ: ATAI)은 정신 건강 장애 치료 혁신에 집중하는 임상 단계의 생명과학 회사로, 2024 Maxim Healthcare 가상 정상 회담에 참여한다고 발표했습니다. 이 행사는 2024년 10월 15일부터 17일까지 예정되어 있습니다.
atai의 참여에 대한 주요 세부사항은 다음과 같습니다:
- 참가자: Srinivas Rao, M.D., Ph.D., 공동 설립자 및 공동 CEO
- 형태: 가상 간담회
- 날짜: 2024년 10월 16일 수요일
- 발표 시간: 오후 3시 30분 EDT
웹캐스트 등록 링크가 제공되며, 발표 후 30일 이내에 atai 웹사이트의 투자자 섹션 이벤트에서 아카이브 재생이 가능할 것입니다.
atai Life Sciences (NASDAQ: ATAI), une entreprise biopharmaceutique en phase clinique axée sur la transformation des traitements des troubles de la santé mentale, a annoncé sa participation au Sommet Virtuel Maxim Healthcare 2024. L'événement est prévu du 15 au 17 octobre 2024.
Les détails clés de la participation d'atai comprennent :
- Participant : Srinivas Rao, M.D., Ph.D., Co-fondateur et Co-CEO
- Format : Discussion virtuelle informelle
- Date : Mercredi 16 octobre 2024
- Heure de présentation : 15h30 EDT
Un lien d'inscription pour le webinaire est fourni et un replay archivé sera disponible dans la section Investisseurs du site web d'atai sous Événements pendant un maximum de 30 jours après la présentation.
atai Life Sciences (NASDAQ: ATAI), ein biopharmazeutisches Unternehmen in klinischen Phasen, das sich auf die Transformation von Behandlungen für psychische Erkrankungen konzentriert, hat seine Teilnahme am 2024 Maxim Healthcare Virtual Summit bekannt gegeben. Die Veranstaltung ist vom 15. bis 17. Oktober 2024 geplant.
Wichtige Details zur Beteiligung von atai umfassen:
- Teilnehmer: Srinivas Rao, M.D., Ph.D., Mitbegründer und Co-CEO
- Format: Virtuelles Gespräch am Lagerfeuer
- Datum: Mittwoch, 16. Oktober 2024
- Präsentationszeit: 15:30 Uhr EDT
Ein Registrierungslink für die Webcast wird bereitgestellt und eine aufgezeichnete Wiederholung wird in der Investoren-Sektion der Website von atai unter Veranstaltungen für bis zu 30 Tage nach der Präsentation verfügbar sein.
- None.
- None.
NEW YORK and BERLIN, Oct. 15, 2024 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced that Srinivas Rao, M.D., Ph.D., the Company’s Co-founder and Co-CEO, is scheduled to participate in the 2024 Maxim Healthcare Virtual Summit taking place from October 15 – 17, 2024. Details of the company’s participation:
Format: Virtual fireside chat
Date: Wednesday, October 16, 2024
Presentation Time: 3:30 P.M. EDT
Webcast: Register here
An archived replay will be available on the Investors section of the atai website under Events for up to 30 days.
About atai Life Sciences
atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders and was founded as a response to the significant unmet need and lack of innovation in the mental health treatment landscape. atai is dedicated to efficiently developing innovative therapeutics to treat depression, anxiety, addiction, and other mental health disorders. By pooling resources and best practices, atai aims to responsibly accelerate the development of new medicines to achieve clinically meaningful and sustained behavioral change in mental health patients. atai's vision is to heal mental health disorders so that everyone, everywhere can live a more fulfilled life. For more information, please visit www.atai.life.
Contact Information
Investor Contact:
IR@atai.life
Media Contact:
PR@atai.life
FAQ
When is atai Life Sciences (ATAI) participating in the 2024 Maxim Healthcare Virtual Summit?
Who will be representing atai Life Sciences (ATAI) at the 2024 Maxim Healthcare Virtual Summit?
What is the format of atai Life Sciences' (ATAI) presentation at the 2024 Maxim Healthcare Virtual Summit?
How long will the replay of atai Life Sciences' (ATAI) presentation be available?
